Pelthos Therapeutics Inc.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Emerging growth company
State of Incorporation NV
Business Address 4020 STIRRUP CREEK DRIVE, DURHAM, NC, 27703
Mailing Address 4020 STIRRUP CREEK DRIVE, DURHAM, NC, 27703
Phone 919-908-2422
Fiscal Year End 1231
EIN 863335449
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 5, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | February 2, 2026 | View on SEC |
| 8-K Current report of material events | January 13, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
| 8-K Current report of material events | January 2, 2026 | View on SEC |
| 3 Initial insider ownership report | December 29, 2025 | View on SEC |
| 4 Insider stock transaction report | December 29, 2025 | View on SEC |
| 8-K Current report of material events | December 23, 2025 | View on SEC |
| 4 Insider stock transaction report | December 19, 2025 | View on SEC |
| 8-K Current report of material events | December 17, 2025 | View on SEC |
Material Events
8-K Strategy Change January 12, 2026
Low Impact
- Pelthos adjusted director compensation to align with peer group standards.
- The changes aim to attract and retain highly skilled and engaged non-employee directors.
8-K Acquisition January 2, 2026
High Impact
- Pelthos Therapeutics Inc. acquired Xeglyze, a head lice treatment, and all related assets from Hatchtech Pty Ltd.
- The acquisition includes all rights, patents, trademarks, technical knowledge, regulatory approvals, inventory, and equipment for Xeglyze.
Related Companies
Companies in the same industry (SIC: 2836)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
CRISPR Therapeutics AG
CRSP Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.